As new data reshape treatment discussions for high-risk localized prostate cancer, understanding the nuances behind the evidence is critical. Ashley E. Ross, MD, PhD, a member of the PROTEUS (Perioperative Treatment with Erleada United with Surgery) steering committee, offers an insider's perspective on the landmark trial, including how it’s adding options for standard of care.
